Pharmacology and Toxicology
-
CETSA MS Profiling for a Comparative Assessment of FDA-Approved Antivirals Repurposed for COVID-19 Therapy Identifies TRIP13 as a Remdesivir Off-Target
This article has 4 authors:Reviewed by ScreenIT
-
In vitro activity of itraconazole against SARS‐CoV‐2
This article has 11 authors:Reviewed by ScreenIT
-
The in-vitro effect of famotidine on SARS-CoV-2 proteases and virus replication
This article has 12 authors:Reviewed by ScreenIT
-
The Hyperlipidaemic Drug Fenofibrate Significantly Reduces Infection by SARS-CoV-2 in Cell Culture Models
This article has 16 authors:Reviewed by ScreenIT
-
Interactions of Potential Anti-COVID-19 Compounds with Multispecific ABC and OATP Drug Transporters
This article has 8 authors:Reviewed by ScreenIT
-
Ivermectin repurposing for COVID-19 therapy: Safety and pharmacokinetic assessment of a novel nasal spray formulation in a pig model
This article has 15 authors:Reviewed by ScreenIT
-
Ozone exposure upregulates the expression of host susceptibility protein TMPRSS2 to SARS-CoV-2
This article has 5 authors:Reviewed by ScreenIT
-
In vitro efficacy of Artemisinin-based treatments against SARS-CoV-2
This article has 12 authors:Reviewed by ScreenIT
-
Platycodin D, a natural component of Platycodon grandiflorum, prevents both lysosome- and TMPRSS2-driven SARS-CoV-2 infection by hindering membrane fusion
This article has 14 authors:Reviewed by ScreenIT
-
Lipid nanoparticle formulation of niclosamide (nano NCM) effectively inhibits SARS-CoV-2 replication in vitro
This article has 9 authors:Reviewed by ScreenIT